Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection
    93.
    发明申请
    Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection 审中-公开
    脂肪乳剂注射密封油,制备方法和制造静脉注射用途

    公开(公告)号:US20060292226A1

    公开(公告)日:2006-12-28

    申请号:US10547027

    申请日:2003-08-11

    IPC分类号: A61K35/12 A61K31/22

    摘要: The present invention relates to a seal oil based lipid emulsion injection, and the main ingredients of which contains 190-210 g/l of refined OMEGA3 seal oil, 11-13 g/l of refined lecithin, 24-26 g/l of glycerol for injection, and balance amount of water. The preparation of the seal oil based lipid emulsion injection comprising the steps of stir and dispersion, high-pressure homogenization, vacuum filtration, antisepsis and encapsulation. The OMEGA3 seal oil lipid based emulsion injections have high content of energy, and thus are highly absorbable to human body, and can not only provide human body with caloricity, but also supply the fatty acids necessary for human body, and can enhance body's immunizing ability, reduce the content of cholesterol, adjust the blood concentration and then be used for anti-inflammation, in particular, it is highly useful for a postoperative patient to restore his strength.

    摘要翻译: 本发明涉及一种基于密封油的脂质乳剂注射液,其主要成分包含190-210g / l精制OMEGA3密封油,11-13g / l精制卵磷脂,24-26g / l甘油 用于注射和平衡水量。 密封油基脂质乳剂注射剂的制备包括搅拌和分散,高压均质,真空过滤,消毒和包封的步骤。 OMEGA3密封油脂基乳液注射剂具有高能量含量,因此对人体具有高吸收性,不仅可以为人体提供热量,还可以提供人体所需的脂肪酸,并能增强人体的免疫能力 降低胆固醇含量,调节血液浓度,然后用于抗炎,特别是术后患者恢复其强度非常有用。

    Multi-channel cross-flow porous device
    95.
    发明申请
    Multi-channel cross-flow porous device 有权
    多通道横流多孔装置

    公开(公告)号:US20060090651A1

    公开(公告)日:2006-05-04

    申请号:US10996522

    申请日:2004-11-24

    IPC分类号: B01D53/02

    摘要: A multi-channel modular device (10) processes between two fluid streams of different compositions. The device (10) includes a porous body (150) having a first plurality of feed-flow pathways (110) disposed in the body (150) for transporting a first stream (180). A pathway wall (114) surrounds each of the first plurality of feed-flow pathways (110) for processing the first stream (180) into a first composition (1852) and a second composition (1802). At least one feed-flow inlet (1101) is disposed in the body (150) for introducing the first stream (180) into the first plurality of feed-flow pathways (110). At least one feed-flow outlet (1102) is disposed in the body (150) for discharging the remaining first stream containing the second composition (1802). At least one second pathway (210) is disposed in the body (150) for transporting a second stream (280) having a second inlet (2101) and a second outlet (2102). A networked plurality of fluid conduits (152) formed in the porous body (150) provides the flow-conduit for the second stream (280) to sweep the first composition (1852) from each of the first plurality of the feed-flow pathways (110) to the second outlet (2102). A vessel (300) ports the inlets (1101 and 2101) and outlets (1102 and 2102) to provide a second stream flow access and for spacing the body within and away from the inner surfaces of the vessel (300) to provide a gap (310) for access. A partition (350) is disposed in the gap between the body and the vessel for diverting the flow within the gap (310).

    摘要翻译: 多通道模块化装置(10)在不同组成的两个流体流之间进行处理。 装置(10)包括具有设置在主体(150)中的第一多个进料流路(110)的多孔体(150),用于输送第一流(180)。 通路壁(114)围绕第一多个进料流通道(110)中的每一个,用于将第一流(180)加工成第一组合物(1852)和第二组合物(1802)。 至少一个进料流入口(1101)设置在主体(150)中,用于将第一流(180)引入第一多个进料通路(110)。 至少一个进料流出口(1102)设置在主体(150)中,用于排出包含第二组合物(1802)的剩余第一流。 至少一个第二通道(210)设置在主体(150)中,用于输送具有第二入口(2101)和第二出口(2102)的第二流(280)。 形成在多孔体(150)中的联网的多个流体导管(152)提供用于第二流(280)的流动管道以从第一组多个进料通道(1852)中的每一个 110)连接到第二出口(2102)。 容器(300)将入口(1101和2101)和出口(1102和2102)连通以提供第二流体流动通道并且用于使体内和容器(300)的内表面间隔开以提供间隙 310)进行访问。 分隔件(350)设置在主体和容器之间的间隙中,用于使流体在间隙(310)内转向。

    Porous glass substrate for field emission device
    96.
    发明申请
    Porous glass substrate for field emission device 审中-公开
    用于场致发射器件的多孔玻璃基板

    公开(公告)号:US20060043861A1

    公开(公告)日:2006-03-02

    申请号:US10929123

    申请日:2004-08-27

    申请人: Wei Liu

    发明人: Wei Liu

    IPC分类号: H01J1/02 H01J9/04 H01J1/05

    摘要: An improved process for growing carbon nanotubes includes steps of providing a glass substrate that has a porous surface, depositing a catalyst into the pores on the porous surface, and growing carbon nanotubes on the substrate. Desirably, the carbon nanotubes are grown using a chemical vapor deposition technique in which the direction of flow of a carbon precursor gas (and any optional diluent gases) is aligned with the desired direction of growth propagation. The techniques of the invention provide a field emission device having more uniformly aligned carbon nanotubes and/or more uniformly sized carbon nanotubes.

    摘要翻译: 用于生长碳纳米管的改进方法包括提供具有多孔表面的玻璃基底,在多孔表面上的孔中沉积催化剂和在基底上生长碳纳米管的步骤。 期望地,使用化学气相沉积技术来生长碳纳米管,其中碳前体气体(和任何任选的稀释气体)的流动方向与所需的生长传播方向对准。 本发明的技术提供了具有更均匀排列的碳纳米管和/或更均匀尺寸的碳纳米管的场致发射器件。

    ENZYMATIC TEMPLATE POLYMERIZATION
    97.
    发明申请
    ENZYMATIC TEMPLATE POLYMERIZATION 失效
    酶模式聚合

    公开(公告)号:US20060041110A1

    公开(公告)日:2006-02-23

    申请号:US10324736

    申请日:2002-12-19

    IPC分类号: C07H21/04 C07H21/02

    摘要: A conductive polymer is formed enzymatically in the presence of a polynucleotide template. The method includes combining at least one redox monomer with a polynucleotide template and a redox enzyme, such as horseradish peroxidase, to form a reaction mixture. The monomer aligns along the template before or during the polymerization. Therefore, the polynucleotide template thereby affects the molecular weight and conformation of the conductive polymer. When the conductive polymer is complexed to a polynucleotide duplex, the conformation of the polynucleotide duplex can be modulated by changing the oxidation state of the conductive polymer.

    摘要翻译: 在多核苷酸模板的存在下,酶促形成导电聚合物。 该方法包括将至少一种氧化还原单体与多核苷酸模板和氧化还原酶如辣根过氧化物酶组合以形成反应混合物。 在聚合之前或聚合过程中,单体沿着模板排列。 因此,多核苷酸模板因此影响导电聚合物的分子量和构象。 当导电聚合物与多核苷酸双链体复合时,可通过改变导电聚合物的氧化态来调节多核苷酸双链体的构象。

    Cell surface molecules as markers and therapeutic agents against kidney cancers
    98.
    发明申请
    Cell surface molecules as markers and therapeutic agents against kidney cancers 审中-公开
    细胞表面分子作为肾癌的标志物和治疗剂

    公开(公告)号:US20050282168A1

    公开(公告)日:2005-12-22

    申请号:US10671740

    申请日:2003-09-29

    IPC分类号: A61K47/48 G01N33/574 C12Q1/68

    摘要: Human cell surface molecules CD70 and CD203c are expressed at higher levels in kidney carcinomas, particularly renal cell carcinomas and clear cell renal cell carcinomas, yet are expressed at low levels in normal kidney and other diseased kidney tissue, and at low levels in other tissues. CD70 and CD203c show specificity towards kidney carcinomas, particularly renal cell carcinomas and clear cell renal cell carcinomas and thus can be used as diagnostic markers and therapeutic targets for these diseases. In addition, antibodies or small molecules against these molecules could be used in treatments towards these diseases.

    摘要翻译: 人类细胞表面分子CD70和CD203c在肾癌,特别是肾细胞癌和透明细胞肾细胞癌中的表达水平较高,但在正常肾脏和其他患病肾组织中表达较低,而在其他组织中呈低水平。 CD70和CD203c对肾癌,特别是肾细胞癌和透明细胞肾细胞癌具有特异性,因此可用作这些疾病的诊断标志物和治疗靶标。 此外,针对这些分子的抗体或小分子可用于治疗这些疾病。

    Architecture and design for central authentication and authorization in an on-demand utility environment using a secured global hashtable
    99.
    发明申请
    Architecture and design for central authentication and authorization in an on-demand utility environment using a secured global hashtable 失效
    在使用安全的全球散列表的按需实用程序环境中进行中央身份验证和授权的架构和设计

    公开(公告)号:US20050273596A1

    公开(公告)日:2005-12-08

    申请号:US10850398

    申请日:2004-05-20

    IPC分类号: H04L29/06 H04L9/00

    摘要: A Centralized Authentication & Authorization (CAA) system that prevents unauthorized access to client data using a secure global hashtable residing in the application server in a web services environment. CAA comprises a Service Request Filter (SRF) and Security Program (SP). The SRF intercepts service requests, extracts the service client's identifier from a digital certificate attached to the request, and stores the identifier in memory accessible to service providers. The client identifier is secured by the SP using a key unique to the client identifier. When the web services manager requests the client identifier, the web services manager must present the key to the SP in order to access the client identifier. Thus, the present invention prevents a malicious user from attempting to obtain sensitive data within the application server once the malicious user has gained access past the firewall.

    摘要翻译: 集中式身份验证和授权(CAA)系统,可以防止使用位于Web服务环境中的应用程序服务器中的安全全局散列表来对客户端数据进行未经授权的访问。 CAA包括服务请求过滤器(SRF)和安全程序(SP)。 SRF拦截服务请求,从附加到请求的数字证书中提取服务客户端的标识符,并将该标识符存储在服务提供商可访问的存储器中。 客户端标识符由SP使用客户端标识符唯一的密钥保护。 当Web服务管理器请求客户端标识符时,Web服务管理器必须向SP呈现密钥以访问客户端标识符。 因此,本发明防止恶意用户一旦恶意用户已经通过防火墙访问,就试图获取应用服务器内的敏感数据。